Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Results of phase I/II clinical trials with ezetimibe, a novel selective cholesterol absorption inhibitor
  1. Home
  2. Publications
  3. Results of phase I/II clinical trials with ezetimibe, a novel selective cholesterol absorption inhibitor

Results of phase I/II clinical trials with ezetimibe, a novel selective cholesterol absorption inhibitor

Author:
  • ESE Stein
    E Stein

Publisher website
Google Scholar
  • 1 June 2001
    • journal article
    • Published by Oxford University Press (OUP) in European Heart Journal Supplements
    • Vol. 3, E11-E16
    • DOI:10.1016/s1520-765x(01)90107-5
Abstract
No abstract available
Keywords
  • LDL CHOLESTEROL LIPOPROTEINS
  • EZETIMIBE
  • CHOLESTEROL ABSORPTION
  • STATINS
  • DRUG INTERACTIONS
  • DIET
  • APPOINTMENTS AND SCHEDULES
  • PHASE 3 CLINICAL TRIALS
  • INFECTIOUS MONONUCLEOSIS
  • SAFETY
  • PHARMACOKINETICS
  • SIMVASTATIN
  • ADVERSE EFFECTS
  • HIGH DENSITY LIPOPROTEIN CHOLESTEROL
  • TRIGLYCERIDES
  • HYPERCHOLESTEROLEMIA
Cited by 56 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.